Nina A. Hering

1.2k total citations
35 papers, 959 citations indexed

About

Nina A. Hering is a scholar working on Neurology, Molecular Biology and Oncology. According to data from OpenAlex, Nina A. Hering has authored 35 papers receiving a total of 959 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Neurology, 12 papers in Molecular Biology and 9 papers in Oncology. Recurrent topics in Nina A. Hering's work include Barrier Structure and Function Studies (13 papers), Gut microbiota and health (9 papers) and Cancer, Stress, Anesthesia, and Immune Response (3 papers). Nina A. Hering is often cited by papers focused on Barrier Structure and Function Studies (13 papers), Gut microbiota and health (9 papers) and Cancer, Stress, Anesthesia, and Immune Response (3 papers). Nina A. Hering collaborates with scholars based in Germany, United States and Austria. Nina A. Hering's co-authors include Jörg–Dieter Schulzke, Michael Fromm, Anja Fromm, Roland Bücker, Rita Rosenthal, Dorothee Günzel, Jörg D. Schulzke, Susanne M. Krug, Hanno Troeger and Susanne Andres and has published in prestigious journals such as PLoS ONE, The Journal of Physiology and The FASEB Journal.

In The Last Decade

Nina A. Hering

34 papers receiving 939 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nina A. Hering Germany 15 395 201 187 186 151 35 959
Licheng Wu United States 14 773 2.0× 313 1.6× 174 0.9× 161 0.9× 89 0.6× 18 1.4k
Hanno Troeger Germany 15 539 1.4× 284 1.4× 186 1.0× 104 0.6× 123 0.8× 27 1.3k
Joerg D. Schulzke Germany 13 349 0.9× 186 0.9× 164 0.9× 119 0.6× 105 0.7× 30 1.1k
Silvia Resta‐Lenert United States 7 650 1.6× 107 0.5× 179 1.0× 197 1.1× 430 2.8× 18 1.1k
Jody Backer Canada 6 619 1.6× 70 0.3× 149 0.8× 201 1.1× 367 2.4× 7 1.0k
Christoph Cichon Germany 11 467 1.2× 81 0.4× 102 0.5× 70 0.4× 205 1.4× 15 773
Jin‐Young Yang South Korea 23 667 1.7× 64 0.3× 150 0.8× 129 0.7× 136 0.9× 46 1.6k
Ganive Bhinder Canada 14 415 1.1× 43 0.2× 133 0.7× 229 1.2× 156 1.0× 17 889
Eiji Miyauchi Japan 18 964 2.4× 82 0.4× 165 0.9× 109 0.6× 306 2.0× 34 1.5k
Karolina S. Jabbar Sweden 6 867 2.2× 58 0.3× 304 1.6× 127 0.7× 202 1.3× 11 1.4k

Countries citing papers authored by Nina A. Hering

Since Specialization
Citations

This map shows the geographic impact of Nina A. Hering's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nina A. Hering with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nina A. Hering more than expected).

Fields of papers citing papers by Nina A. Hering

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nina A. Hering. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nina A. Hering. The network helps show where Nina A. Hering may publish in the future.

Co-authorship network of co-authors of Nina A. Hering

This figure shows the co-authorship network connecting the top 25 collaborators of Nina A. Hering. A scholar is included among the top collaborators of Nina A. Hering based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nina A. Hering. Nina A. Hering is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Günzel, Dorothee, et al.. (2025). Matrix-free human 2D organoids recapitulate duodenal barrier and transport properties. BMC Biology. 23(1). 2–2. 3 indexed citations
2.
Schulzke, Jörg–Dieter, et al.. (2025). Tumour necrosis factor-α induces macromolecule translocation in HIV-derived duodenal organoids. Frontiers in Immunology. 16. 1563702–1563702. 1 indexed citations
3.
Carstens, Jan, et al.. (2024). Mitochondrial respiration in peripheral arterial disease depends on stage severity. Journal of Cellular and Molecular Medicine. 28(8). e18126–e18126. 2 indexed citations
4.
Hering, Nina A., Marco Arndt, Johannes C. Lauscher, et al.. (2023). Targeting Interleukin-6/Glycoprotein-130 Signaling by Raloxifene or SC144 Enhances Paclitaxel Efficacy in Pancreatic Cancer. Cancers. 15(2). 456–456. 12 indexed citations
5.
Stoyanova, Ani K., Arne Sattler, Nina A. Hering, et al.. (2023). Immune Phenotypic Characterization of a TRAIL-Knockout Mouse. Cancers. 15(5). 1475–1475. 1 indexed citations
6.
Hering, Nina A., et al.. (2023). Myrrh protects against IL-13-induced epithelial barrier breakdown in HT-29/B6 cells. Frontiers in Pharmacology. 14. 1301800–1301800. 3 indexed citations
7.
Hering, Nina A., et al.. (2023). The Impact of TRAIL on the Immunological Milieu during the Early Stage of Abdominal Sepsis. Cancers. 15(6). 1773–1773. 4 indexed citations
8.
Carstens, Jan, et al.. (2022). Effect of Revascularization on Intramuscular Vascular Endothelial Growth Factor Levels in Peripheral Arterial Disease. Biomedicines. 10(2). 471–471. 1 indexed citations
9.
Hering, Nina A., Marco Arndt, Sefer Elezkurtaj, et al.. (2022). Gp130 is expressed in pancreatic cancer and can be targeted by the small inhibitor molecule SC144. Journal of Cancer Research and Clinical Oncology. 149(1). 271–280. 7 indexed citations
10.
Hering, Nina A., Benjamin Weixler, Raoul A. Droeser, et al.. (2021). Blockage of Cholinergic Signaling via Muscarinic Acetylcholine Receptor 3 Inhibits Tumor Growth in Human Colorectal Adenocarcinoma. Cancers. 13(13). 3220–3220. 21 indexed citations
11.
Hartmann, Lisa, et al.. (2021). Effect of bowel preparation on intestinal permeability and inflammatory response during postoperative ileus in mice. Surgery. 170(5). 1442–1447. 1 indexed citations
12.
Hering, Nina A., Lisa Hartmann, Peter Čamaj, et al.. (2020). Raloxifene inhibits pancreatic adenocarcinoma growth by interfering with ERβ and IL-6/gp130/STAT3 signaling. Cellular Oncology. 44(1). 167–177. 18 indexed citations
13.
Hering, Nina A., et al.. (2018). Differential Desensitisation of Afferent NerveFibres by Iberis amara (STW 6) and Iberogast(STW 5) in the Murine Colon. American journal of phytomedicine and clinical therapeutics. 6(1). 2 indexed citations
14.
Bücker, Roland, Susanne M. Krug, Verena Moos, et al.. (2017). Campylobacter jejuni impairs sodium transport and epithelial barrier function via cytokine release in human colon. Mucosal Immunology. 11(2). 474–485. 48 indexed citations
15.
Hering, Nina A., Anja Fromm, Judith Kikhney, et al.. (2015). Yersinia enterocoliticaAffects Intestinal Barrier Function in the Colon. The Journal of Infectious Diseases. 213(7). 1157–1162. 13 indexed citations
16.
Whelan, Rose, Sebastian Rausch, Friederike Ebner, et al.. (2014). A Transgenic Probiotic Secreting a Parasite Immunomodulator for Site-Directed Treatment of Gut Inflammation. Molecular Therapy. 22(10). 1730–1740. 60 indexed citations
17.
Hering, Nina A., J Richter, Anja Fromm, et al.. (2013). TcpC protein from E. coli Nissle improves epithelial barrier function involving PKCζ and ERK1/2 signaling in HT-29/B6 cells. Mucosal Immunology. 7(2). 369–378. 57 indexed citations
18.
Hering, Nina A., Michael Fromm, & Jörg–Dieter Schulzke. (2012). Determinants of colonic barrier function in inflammatory bowel disease and potential therapeutics. The Journal of Physiology. 590(5). 1035–1044. 224 indexed citations
19.
Hering, Nina A., Susanne Andres, Anja Fromm, et al.. (2011). Transforming Growth Factor-β, a Whey Protein Component, Strengthens the Intestinal Barrier by Upregulating Claudin-4 in HT-29/B6 Cells1,2. Journal of Nutrition. 141(5). 783–789. 87 indexed citations
20.
Hering, Nina A. & Jörg–Dieter Schulzke. (2009). Therapeutic Options to Modulate Barrier Defects in Inflammatory Bowel Disease. Digestive Diseases. 27(4). 450–454. 99 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026